scotland coronary prevention study
Recently Published Documents


TOTAL DOCUMENTS

56
(FIVE YEARS 0)

H-INDEX

21
(FIVE YEARS 0)

2017 ◽  
Vol 2016 (4) ◽  
Author(s):  
Mohammed Amin Kashef ◽  
Gregory Giugliano

The West of Scotland Coronary Prevention Study (WOSCOPS) was a randomized, placebo- controlled, primary prevention trial of pravastatin in men aged 45 to 64 (mean age of 55 years) with no history of myocardial infarction at randomization. A total of 6,595 men, with a mean (SD) plasma cholesterol level of 272 (23) mg/dL and mean (SD) low density lipoprotein cholesterol (LDL-C) of 192 (17) mg/dL were randomly assigned to receive pravastatin 40 mg daily or placebo for five years. The primary outcome was a composite of death from coronary heart disease (CHD) and nonfatal myocardial infarction. There was a 31% relative reduction in the primary outcome with pravastatin. There was similar reduction in risk of nonfatal myocardial infarction, death from CHD and death from all cardiovascular causes with no increased risk of death from non-cardiovascular causes nor an increase in incident cancers. 


2014 ◽  
Vol 10 (3) ◽  
pp. 127
Author(s):  
Saraheni Saraheni ◽  
I Dewa Putu Pramantara ◽  
Herni Astuti

Background: Metabolic syndrome (MetS) is a disease of disorder of lipid and nonlipid metabolism. The West of Scotland Coronary Prevention Study found that men with MetS had probability 3.7 dysfunctions of erection (ED) by using International Index of Erectile Function (IIEF). Patient with heart disease had the risk 2 times to get ED, hypertension was 1.5-2 times, DM was 3-4 times, depression was 2-3.5 times, testosterone deficiency syndrome (TDS) was 1.5-2 times, and high cholesterol was 4 times. The nutrient deficiency of zinc (Zn) and magnesium (Mg) was suspected being the main component which had a role in resisting a sexuality growth and maturation process.Objective: Knowing the correlation of Zn and Mg feeding with erection dysfunction in MetS person.Method: This study was observational analytic study, with case-control design in the patient aged 30-60 years old. The respondent in this study was people with MetS according to WHO criterion. There was 82 patient divided into two groups, consist of 41 cases of MetS and ED, 41 cases with the normal patient. The data collected by interview, laboratory assessment and anthropometric measurement. The data analysis using univariate, bivariate and multivariate analysis using multiple logistic regression.Results: There was significant correlation between Zn feeding and ED (OR=7.15; 95% Cl=1.47-34.71; p=0.007) and there was significant correlation between Mg feeding with ED (OR=3.34; 95% Cl=1.07-10.4; p=0.033). The end result of the multivariate analysis showed the risk variable to the ED event, that was Zn feeding with OR=15.41. If the intake of Zn accompanied with risk factors associated as a cause of ED, multivariate analysis showed HbA1c’s degree with OR=12.57; triglyceride (OR=10.47); blood pressure (OR=5.82); and abdominal obesity (OR=6.94). The result shows that these risk factors can aggravate or anticipate the onset of dysfunction erection beside low Zn intake.Conclusion: There was statistically significant correlation between Zn and Mg feeding with erection dysfunction in MetS patient.


2009 ◽  
Vol 63 (10) ◽  
pp. 839-841 ◽  
Author(s):  
G D Batty ◽  
Y Wang ◽  
S W Brouilette ◽  
P Shiels ◽  
C Packard ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document